InnovaHealth Partners

InnovaHealth Partners is a private equity firm based in New York, founded in 2016, that focuses on investments in the medical technology sector. The firm specializes in buyout and growth investments, primarily targeting late-stage companies that develop medical devices and disruptive technologies. InnovaHealth Partners seeks to acquire controlling positions as a lead investor in its portfolio companies, which are typically located in the United States, Europe, and Israel. The firm aims to identify and support innovative organizations that can advance healthcare through technology and improved medical solutions.

Toby Cosgrove

Senior Partner

Ross Julian

Associate Director

11 past transactions

Route 92

Series F in 2024
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.

Materna Medical

Venture Round in 2024
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.

Route 92

Series F in 2023
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.

Switchboard Health

Seed Round in 2023
Switchboard Health, founded in 2023 and based in Boise, Idaho, provides a specialty care network platform designed to improve access to integrated and comprehensive healthcare. The company focuses on helping payers, health systems, employers, and at-risk providers utilize virtual care solutions effectively. By activating individuals in need of care and connecting them with appropriate providers, Switchboard Health streamlines the specialty referral process. The platform includes navigator support and integrated data capabilities, allowing for effective tracking of care quality and outcomes. This approach aims to enhance patient experiences across various care journeys while simultaneously reducing costs for employers and payers through improved navigation and coordination of care.

Radiaction

Series C in 2023
Radiaction Medical, Ltd., based in Tel Aviv, Israel, is advancing radiation protection for medical teams in high-exposure fields such as interventional cardiology and electrophysiology. The company has developed a unique radiation shielding system known as Radiaction, which is a plug-and-play solution designed to be integrated with C-arm systems. Unlike traditional methods that rely on lead aprons or shields, Radiaction proactively blocks over 90% of scatter radiation at its source, ensuring comprehensive protection for all personnel in the operating room. This innovative approach not only enhances safety but also addresses the limitations of existing radiation protection solutions. Radiaction has received both CE Marking and FDA clearance, allowing it to be marketed in North America. The company was founded by Amir Belson, MD, and is backed by lead investor InnovaHealth Partners, LP.

Monteris Medical

Venture Round in 2022
Monteris Medical, Inc. is a medical device company that specializes in developing and marketing technologies for minimally invasive neurosurgery, particularly focused on the treatment of brain lesions. The company's flagship product, the NeuroBlate System, is a laser thermotherapy system designed for the volumetric ablation of pathological brain lesions, including both primary and metastatic tumors. This system utilizes magnetic resonance imaging (MRI) guidance and applies focused laser energy to effectively target and ablate tumors while minimizing damage to surrounding healthy tissue. Monteris Medical also offers various stereotactic anchoring devices for precise image-guided trajectory alignment, as well as stabilization systems for MRI-based procedures that require head fixation. Founded in 1999 and headquartered in Plymouth, Minnesota, the company serves neurosurgeons across the United States through a dedicated sales force. Monteris Medical was previously known as AutoLITT until rebranding in 2003.

Materna Medical

Series B in 2022
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.

Radiaction

Venture Round in 2022
Radiaction Medical, Ltd., based in Tel Aviv, Israel, is advancing radiation protection for medical teams in high-exposure fields such as interventional cardiology and electrophysiology. The company has developed a unique radiation shielding system known as Radiaction, which is a plug-and-play solution designed to be integrated with C-arm systems. Unlike traditional methods that rely on lead aprons or shields, Radiaction proactively blocks over 90% of scatter radiation at its source, ensuring comprehensive protection for all personnel in the operating room. This innovative approach not only enhances safety but also addresses the limitations of existing radiation protection solutions. Radiaction has received both CE Marking and FDA clearance, allowing it to be marketed in North America. The company was founded by Amir Belson, MD, and is backed by lead investor InnovaHealth Partners, LP.

Route 92

Series E in 2021
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.

Radiaction

Series B in 2020
Radiaction Medical, Ltd., based in Tel Aviv, Israel, is advancing radiation protection for medical teams in high-exposure fields such as interventional cardiology and electrophysiology. The company has developed a unique radiation shielding system known as Radiaction, which is a plug-and-play solution designed to be integrated with C-arm systems. Unlike traditional methods that rely on lead aprons or shields, Radiaction proactively blocks over 90% of scatter radiation at its source, ensuring comprehensive protection for all personnel in the operating room. This innovative approach not only enhances safety but also addresses the limitations of existing radiation protection solutions. Radiaction has received both CE Marking and FDA clearance, allowing it to be marketed in North America. The company was founded by Amir Belson, MD, and is backed by lead investor InnovaHealth Partners, LP.

Koelis

Acquisition in 2019
Koelis is a company that specializes in developing medical imaging products specifically for urologists. The firm has created advanced imaging systems that are designed to assist in guiding and mapping urological interventions within hospitals. Its platform features innovative organ-based tracking technology and multiparametric image fusion, which together generate a digitized three-dimensional (3D) map tailored to individual patients’ prostate anatomy. This technology enhances the precision of diagnostics and improves the detection rates of prostate cancer, thereby supporting urologists and radiologists in delivering comprehensive management services for prostate cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.